2 unknown, 1 completed, 1 withdrawn. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Unknown 2, Completed 1, Withdrawn 1 |
Follow SCCHN: new trials by email Literature Review of SCCHN trials Research Report on SCCHN
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Chemo-embolization for Head and Neck Cancer Cisplatin - SCCHN, Squamous Cell Carcinoma | Phase 2 | Withdrawn | University of Alabama at Birmingham | 2027-05-01 | 2025-04-27 | |
| Nivolumab Plus Pemetrexed for Head and Neck Squamous Cell Carcinoma Combination Product: Nivolumab with Pemetrexed - SCCHN | Phase 2 | Completed | AHS Cancer Control Alberta | 6 | 2020-03-19 | 2024-06-14 |
| Combination Therapy With NC-6004 and Pembrolizumab in Head and Neck Cancer Subjects Who Have Failed Platinum Regimen NC-6004, Pembrolizumab - SCCHN | Phase 2 | Unknown | NanoCarrier Co., Ltd. | 136 | 2019-07-01 | 2021-03-17 |
| Safety and Efficacy Study of Target Therapy Combined With Radiotherapy to Treat Senile Locally Advanced SCCHN Nimotuzumab and Radiotherapy - SCCHN | Phase 2 | Unknown | Peking University | 92 | 2011-03-01 | 2011-07-13 |
Carcinoma, Squamous Cell (1) · Squamous Cell Carcinoma of Head and Neck (1)
Carcinoma (1) · Head and Neck Neoplasms (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Glandular and Epithelial (1) · Neoplasms, Squamous Cell (1)
Cisplatin (1) · Nivolumab (1) · Pemetrexed (1) · Radiotherapy (1) · demplatin pegraglumer (1) · nimotuzumab (1) · pembrolizumab (1)
AHS Cancer Control Alberta (1) · NanoCarrier Co., Ltd. (1) · Peking University (1) · University of Alabama at Birmingham (1)
Canada (1) · Croatia (1) · Czechia (1) · Hungary (1) · Poland (1) · Russia (1) · Serbia (1) · Taiwan (1) · Ukraine (1) · United States (1)
Atsushi Osada (1) · Hatim Karachiwala, MD FRCPC (1) · Jesse Jones, MD (1) · Sun Yan, MD (1)
PMID 11531245, PMID 18784101, PMID 19934295, PMID 21766301, PMID 22996369, PMID 23726971, PMID 24196717, PMID 25941355, PMID 28779022, PMID 7165009